Your browser doesn't support javascript.
loading
Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy.
Steelman, L S; Franklin, R A; Abrams, S L; Chappell, W; Kempf, C R; Bäsecke, J; Stivala, F; Donia, M; Fagone, P; Nicoletti, F; Libra, M; Ruvolo, P; Ruvolo, V; Evangelisti, C; Martelli, A M; McCubrey, J A.
Affiliation
  • Steelman LS; Department of Microbiology and Immunology, Brody School of Medicine at East Carolina University, Greenville, NC 27858, USA.
Leukemia ; 25(7): 1080-94, 2011 Jul.
Article in En | MEDLINE | ID: mdl-21494257
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia / Ras Proteins / Mitogen-Activated Protein Kinase Kinases / MAP Kinase Signaling System / Raf Kinases / Extracellular Signal-Regulated MAP Kinases / Molecular Targeted Therapy / Neoplasm Proteins / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2011 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia / Ras Proteins / Mitogen-Activated Protein Kinase Kinases / MAP Kinase Signaling System / Raf Kinases / Extracellular Signal-Regulated MAP Kinases / Molecular Targeted Therapy / Neoplasm Proteins / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2011 Document type: Article Affiliation country: Country of publication: